The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117198127 11719812 7 F 20150414 20160831 20151110 20160907 EXP CA-ROCHE-1657571 ROCHE 40.95 YR M Y 0.00000 20160908 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117198127 11719812 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 300 MG SOLUTION FOR INJECTION
117198127 11719812 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0001E,S0003B 103976 SOLUTION FOR INJECTION
117198127 11719812 14 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
117198127 11719812 15 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown U 0
117198127 11719812 16 C DILANTIN PHENYTOIN 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117198127 11719812 1 Asthma
117198127 11719812 14 Product used for unknown indication
117198127 11719812 15 Product used for unknown indication
117198127 11719812 16 Seizure

Outcome of event

Event ID CASEID OUTC COD
117198127 11719812 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117198127 11719812 Blood pressure increased
117198127 11719812 Dyspnoea
117198127 11719812 Heart rate increased
117198127 11719812 Nasopharyngitis
117198127 11719812 Respiratory disorder
117198127 11719812 Weight increased
117198127 11719812 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117198127 11719812 1 20150312 0
117198127 11719812 2 20150414 0
117198127 11719812 3 20150507 0
117198127 11719812 4 20150604 0
117198127 11719812 5 20150702 0
117198127 11719812 6 20150730 0
117198127 11719812 7 20151001 0
117198127 11719812 8 20151029 0
117198127 11719812 9 20151126 0
117198127 11719812 10 20151224 0
117198127 11719812 11 20160121 0
117198127 11719812 12 20160512 0
117198127 11719812 13 20160831 0